Structural insights into activation mechanisms on NADase of the bacterial DSR2 anti-phage defense system

A cryptic site in class 5 epitope of SARS-CoV-2 RBD maintains highly conservation across natural isolates

Major HBV splice variant encoding a novel protein important for infection

Risedronate-functionalized manganese-hydroxyapatite amorphous particles: A potent adjuvant for subunit vaccines and cancer immunotherapy

Rational design of a cross-type HPV vaccine through immunodominance shift guided by a cross-neutralizing antibody

Neutralizing antibodies against EBV gp42 show potent <i>in vivo</i> protection and define novel epitopes

Non-overlapping epitopes on the gHgL-gp42 complex for the rational design of a triple-antibody cocktail against EBV infection

Structural basis for broad neutralization of human antibody against Omicron sublineages and evasion by XBB variant

Targeting herpesvirus entry complex and fusogen glycoproteins with prophylactic and therapeutic agents

Two antibodies show broad, synergistic neutralization against SARS-CoV-2 variants by inducing conformational change within the RBD

Risedronate-Functionalized Manganese-Calcium Phosphate Nanoparticles: A Potent Adjuvant for Subunit Vaccines and Cancer Immunotherapy

Structure and proposed DNA delivery mechanism of a marine roseophage

Critical Residues Involved in the Coassembly of L1 and L2 Capsid Proteins of Human Papillomavirus 16

Truncated glycoprotein E of varicella-zoster virus is an ideal immunogen for <i>Escherichia coli</i>-based vaccine design

Lineage-mosaic and mutation-patched spike proteins for broad-spectrum COVID-19 vaccine

Editorial: Antiviral drugs and vaccines against important human respiratory viruses

Omics-guided bacterial engineering of Escherichia coli ER2566 for recombinant protein expression

Characterization of an Escherichia coli-derived triple-type chimeric vaccine against human papillomavirus types 39, 68 and 70

A bacterially expressed triple-type chimeric vaccine against human papillomavirus types 51, 69, and 26

A potent synthetic nanobody with broad-spectrum activity neutralizes SARS-CoV-2 virus and the Omicron variant BA.1 through a unique binding mode

Structural basis for the synergistic neutralization of coxsackievirus B1 by a triple-antibody cocktail

Identification of a cross-neutralizing antibody that targets the receptor binding site of H1N1 and H5N1 influenza viruses

Endodomain truncation of the HIV-1 envelope protein improves the packaging efficiency of pseudoviruses

The neutralizing breadth of antibodies targeting diverse conserved epitopes between SARS-CoV and SARS-CoV-2

Protective anti-gB neutralizing antibodies targeting two vulnerable sites for EBV-cell membrane fusion

Baculovirus Display of Varicella-Zoster Virus Glycoprotein E Induces Robust Humoral and Cellular Immune Responses in Mice

Three SARS-CoV-2 antibodies provide broad and synergistic neutralization against variants of concern, including Omicron

A Neutralizing Antibody Targeting gH Provides Potent Protection against EBV Challenge In Vivo

A Bacterially Expressed SARS-CoV-2 Receptor Binding Domain Fused With Cross-Reacting Material 197 A-Domain Elicits High Level of Neutralizing Antibodies in Mice

Structures of pseudorabies virus capsids

Immune escape by SARS-CoV-2 Omicron variant and structural basis of its effective neutralization by a broad neutralizing human antibody VacW-209

A stepwise docking molecular dynamics approach for simulating antibody recognition with substantial conformational changes

Unsupervised Cryo-EM Images Denoising and Clustering Based on Deep Convolutional Autoencoder and K-Means plus

Engineering for an HPV 9-valent vaccine candidate using genomic constitutive over-expression and low lipopolysaccharide levels in Escherichia coli cells

Cross-neutralizing antibodies bind a SARS-CoV-2 cryptic site and resist circulating variants

A recombinant spike protein subunit vaccine confers protective immunity against SARS-CoV-2 infection and transmission in hamsters

A Novel Clustering Method Using Variational Autoencoder with Reliable Sample Decision and Balanced K-Means++ for Single-particle Cryo-EM Images

Structural Basis for the Shared Neutralization Mechanism of Three Classes of Human Papillomavirus Type 58 Antibodies with Disparate Modes of Binding

Cryo-EM structures reveal the molecular basis of receptor-initiated coxsackievirus uncoating

Rapid Development of SARS-CoV-2 Spike Protein Receptor-Binding Domain Self-Assembled Nanoparticle Vaccine Candidates

Virus-Free and Live-Cell Visualizing SARS-CoV-2 Cell Entry for Studies of Neutralizing Antibodies and Compound Inhibitors

Immunization with a Self-Assembled Nanoparticle Vaccine Elicits Potent Neutralizing Antibody Responses against EBV Infection

Machine Learning for Structure Determination in Single-Particle Cryo-Electron Microscopy: A Systematic Review

Near-atomic cryo-electron microscopy structures of varicella-zoster virus capsids

Genetically engineered magnetic nanocages for cancer magneto-catalytic theranostics

Structural characterization of a neutralizing mAb H16.001, a potent candidate for a common potency assay for various HPV16 VLPs

Genome re-sequencing and reannotation of the Escherichia coli ER2566 strain and transcriptome sequencing under overexpression conditions

Rational design of a multi-valent human papillomavirus vaccine by capsomere-hybrid co-assembly of virus-like particles

Recent Progress on the Versatility of Virus-Like Particles

Identification of Antibodies with Non-overlapping Neutralization Sites that Target Coxsackievirus A16

A unique B cell epitope-based particulate vaccine shows effective suppression of hepatitis B surface antigen in mice

SARS-CoV-2 spike produced in insect cells elicits high neutralization titres in non-human primates

Viral neutralization by antibody-imposed physical disruption

Altered antigenicity and immunogenicity of human papillomavirus virus-like particles in the presence of thimerosal

Construction of a bacterial surface display system based on outer membrane protein F

Hepatitis E vaccine candidate harboring a non-particulate immunogen of E2 fused with CRM197 fragment A

Characterization of native-like HIV-1 gp140 glycoprotein expressed in insect cells

An HRP-labeled lateral flow immunoassay for rapid simultaneous detection and differentiation of influenza A and B viruses

Neutralization sites of human papillomavirus-6 relate to virus attachment and entry phase in viral infection

Atomic structures of enterovirus D68 in complex with two monoclonal antibodies define distinct mechanisms of viral neutralization

An IgM antibody targeting the receptor binding site of influenza B blocks viral infection with great breadth and potency

Rational design of a triple-type human papillomavirus vaccine by compromising viral-type specificity

T=4 Icosahedral HIV-1 Capsid As an Immunogenic Vector for HIV-1 V3 Loop Epitope Display

N-terminal truncations on L1 proteins of human papillomaviruses promote their soluble expression in Escherichia coli and self-assembly in vitro

Discovery and structural characterization of a therapeutic antibody against coxsackievirus A10

Identification of Strategic Residues at the Interface of Antigen-Antibody Interactions by In Silico Mutagenesis

A multimechanistic antibody targeting the receptor binding site potently cross-protects against influenza B viruses

Atomic structures of Coxsackievirus A6 and its complex with a neutralizing antibody

A novel inactivated enterovirus 71 vaccine can elicit cross-protective immunity against coxsackievirus A16 in mice

A shared N-terminal hydrophobic tail for the formation of nanoparticulates

The C-Terminal Arm of the Human Papillomavirus Major Capsid Protein Is Immunogenic and Involved in Virus-Host Interaction

Virus-mimetic nanovesicles as a versatile antigen-delivery system